Long-term outcome of patient choice of surgery or active surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal cancer
European Journal of Surgical Oncology · 2026-01 · 52 (1) · 111171
DOI: 10.1016/j.ejso.2025.111171 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2026-01. Verfasst von Níamh M Smyth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Connolly Hospital, Dublin, Ireland; Department of Surgery, Royal College of Surgeons Ireland, 123 Saint Stephen's Green, Dubli…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoadjuvant Therapy, Esophagectomy, Watchful Waiting. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Conventional treatment pathways propel oesophageal cancer patients who achieve a clinical complete response (cCR) to neoadjuvant chemoradiation therapy (NCRT) towards oesophagectomy, though a proportion of cCR patients will have a pathological complete response (pCR) and cannot benefit from resection but are exposed to its surgical and quality-of-life risks. While we cannot accurately identify pCR patients prior to resection, we hypothesised that affording cCR patients a choice between immediate surgery and active surveillance would not compromise their overall survival. METHODS: A retrospective single centre analysis was performed. In total, 205 oesophageal cancer patients were treated with curative intent in one surgical unit between 1998 and 2019, of these 80 patients (52 %) had a cCR to NCRT. All cCR patients had been offered the choice of immediate surgery or active surveillance, with salvage oesophagectomy if locoregional disease recurred. A prospectively maintained database, electronic hospital and community care records were reviewed. All patients were followed until death and censored at five years following diagnosis. RESULTS: Of 80 cCR patients, 51 (63.8 %; mean age 59-years) chose surgery and 29 (36.3 %; mean age 70-years) chose active surveillance [of whom 7 (24.1 %) developed locoregional recurrence and were offered salvage surgery]. Median age-adjusted survival for the surveillance group was 28.1 (IQR 15.5 to 60.0) months and 52.0 months for the surgery group (IQR 12.3 to 60.0), which was not statistically significant (p = 0.485). CONCLUSION: This study found that affording oesophageal cancer patients with a cCR to NCRT the choice between immediate surgery and active surveillance did not compromise their overall survival and supports future studies with larger patient populations to further examine this hypothesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Connolly Hospital, Dublin, Ireland; Department of Surgery, Royal College of Surgeons Ireland, 123 Saint Stephen's Green, Dublin, Ireland. Electronic address: niamhmarysmyth@rcsi.com.
- Department of Surgery, Connolly Hospital, Dublin, Ireland; Division of Traumatology, Surgical Critical Care and Emergency Surgery, University of Pennsylvania, Philadelphia, USA.
- Department of Surgery, Connolly Hospital, Dublin, Ireland.
- Healthcare Outcomes Research Centre, School of Population Health RCSI, Lower Mercer Street, Dublin, Ireland.
- Department of Surgery, Royal College of Surgeons Ireland, 123 Saint Stephen's Green, Dublin, Ireland; Department of Surgery, Beaumont Hospital, Dublin, Ireland.
- Department of Surgery, Royal College of Surgeons Ireland, 123 Saint Stephen's Green, Dublin, Ireland.
Zitieren
APA
Smyth, N. M., Bass, G. A., Kharytaniuk, N., Sorensen, J., Hill, A. D. K., & Walsh, T. N. (2026). Long-term outcome of patient choice of surgery or active surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal cancer. European Journal of Surgical Oncology, 52(1), 111171. https://doi.org/10.1016/j.ejso.2025.111171
Vancouver
Smyth NM, Bass GA, Kharytaniuk N, Sorensen J, Hill ADK, Walsh TN. Long-term outcome of patient choice of surgery or active surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal cancer. European Journal of Surgical Oncology. 2026;52(1):111171. doi:10.1016/j.ejso.2025.111171
BibTeX
@article{Smyth2026,
author = {Smyth, Níamh M and Bass, Gary A and Kharytaniuk, Natallia and Sorensen, Jan and Hill, Arnold D K and Walsh, Thomas N},
title = {Long-term outcome of patient choice of surgery or active surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal cancer},
journal = {European Journal of Surgical Oncology},
year = {2026},
volume = {52},
number = {1},
pages = {111171},
doi = {10.1016/j.ejso.2025.111171}
}
EUVIMED